Metformin Vitabalans (Metformin Hydrochloride)

Metformin works by activating AMP‑activated protein kinase, which suppresses hepatic glucose production, enhances insulin‑mediated glucose uptake in muscle and fat, and modestly reduces intestinal glucose absorption, thereby lowering overall blood glucose levels.

The exact dose of Metformin Vitabalans is determined by the prescribing clinician based on the individual’s medical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of metformin during pregnancy or lactation is not fully established. Healthcare providers weigh potential benefits against possible risks, and the decision to use metformin in these situations should be made in consultation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metformin is a first‑line therapy for type 2 diabetes and differs from sulfonylureas, DPP‑4 inhibitors, or insulin by primarily reducing hepatic glucose output and improving insulin sensitivity, rather than stimulating insulin secretion. It is generally weight‑neutral and has a low risk of hypoglycemia when used alone.

Metformin Vitabalans should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Metformin Vitabalans is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast studies without appropriate renal monitoring.